Tumores Neuroendocrinos: un desafío transversal
Palabras clave:
Biomarkers, Tumor, Malignant Carcinoid Syndrome, Neuroendocrine Tumors, SomatostatinResumen
Neuroendocrine Tumors (NETs) encompass a wide variety of tumors arising from neuroendocrine cells, which produce bioactive substances. The incidence of NETs increased significantly lately, becoming one of the most common tumors of the digestive tract. Their clinical presentation is as diverse as their capacity for hormone production. Carcinoid syndrome is the most common hormonal syndrome produced by NETs and is characterized by diarrhea, flushing and cardiac valvular lesions. New research brought multiple changes in the classification of these neoplasms and a new understanding about their diagnosis and treatment, promoting a multidisciplinary approach. Somatostatin analogues, radiation, biological, and cytotoxic drugs have improved the prognosis of these patients, which entails a great challenge for healthcare providers.Descargas
Publicado
2021-01-12
Cómo citar
Carrillo, D., Muñoz-Medel, M., Retamal, I., Pinto D, M., Bravo, M. L., Nervi, B., Peña, J., Valenzuela, Y., Guarda, F. J., Nilo, F., Bello, F., Orellana, P., Vicentini, D., Quintana, J. C., Torres, P. J., Leal, J. L., & Garrido, M. (2021). Tumores Neuroendocrinos: un desafío transversal. Revista Médica De Chile, 149(6). Recuperado a partir de https://revistamedicadechile.cl/index.php/rmedica/article/view/8480
Número
Sección
Artículos de revisión